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Case Report
ABSTRACT
Gonadal dysgenesis is a congenital condition in which there is gonadal dysfunction as a result of anomalies of sex chromosomes 
or mutations in the genes involved in the development of the indifferent embryonic gonads. It usually remains undiagnosed 
until when puberty fails to occur in patients. There is absence of development of female secondary sexual characteristics 
and primary amenorrhea. Infertility is an important manifestation of this condition, and this has a significant impact on the 
quality of the reproductive and family life of the patients, especially in areas where importance is placed on childbirth in 
marriages. This case is that of a woman with pure 46, XX gonadal dysgenesis with primary infertility who was able to achieve 
conception following IVF (in‑vitro fertilization) with donor oocyte at our facility. This has helped to buttress the fact that with 
proper evaluation and effective application of hormone replacement therapy and assisted reproductive techniques, women 
with such cases can be helped to achieve conception and give birth.
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Introduction
Gonadal dysgenesis is a subset of disorders of sexual 
development characterized by incomplete or defective 
formation of the gonads due to either structural or numerical 
anomalies of the sex chromosomes or mutations in the 
genes involved in the development of the gonads.[1] It is a 
congenital disorder of the development of the reproductive 
system with usual gynecological manifestations of primary 
amenorrhea and infertility. There is usually no suspicion until 
puberty fails to occur and patient does not menstruate as at 
when expected.[2]
Gonadal dysgenesis is characterized by nonfunctional streak 
ovaries with variable degree of hypoestrogenism depending 
on the level of gonadal development. It is associated with high 
levels of follicle stimulating hormone (FSH) and luteinizing 
hormone (LH) with poorly developed secondary sexual 
characteristics.[2] Though the cause is unclear, mutations in 
the SRY-gene and abnormalities in FSH-receptor have been 
implicated.[3]
It can be classified based on the gonadal morphology into 
complete (pure) gonadal dysgenesis in which there is a female 
phenotype with no gonadal differentiation, and partial gonadal 
dysgenesis in which there is incomplete testis differentiation 
with an external phenotype that depends on the degree of 
testicular function.[4] Based on the karyotype, the variants include 
Turners syndrome (45, XO), XX gonadal dysgenesis (46, XX), 
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Swyer syndrome (46, XY), and the mixed gonadal dysgenesis (45, 
X/46, XY) mosaicism.[5] This is a case of a nulliparous Nigerian 
woman with pure 46, XX gonadal dysgenesis who has been 
previously managed for primary amenorrhea and thereafter 
presented at our center on account of primary infertility.
Case Report
Mrs. A.F. was a 34-year-old married woman who lived together 
with her husband for 6 years without achieving conception 
despite satisfactory unprotected sexual intercourse 2–3 times 
per week. She had history of primary amenorrhea and had 
to use oral contraceptive pills to initiate and induce menses 
since 19 years of age. She attained adrenarche at 15 years 
and thelarche at 19 years.
She had no anterior neck swelling, heat or cold intolerance, 
palpitations or fine tremors. There was no recurrent frontal 
headache, changes in sense of smell, or abnormal milky 
nipple discharge. There was no increasing acne, deepening 
of voice, or abnormal male hair pattern, and also no history 
of anosmia or deafness. She could not ascertain the use of 
diethylstilbestrol (DES) in-utero. She did not consume alcohol 
nor smoked cigarette.
She had laparoscopy for the evaluation of primary amenorrhea 
at a teaching hospital in 2000 where poorly developed ovaries 
were found. She was not a known hypertensive, diabetic, 
peptic ulcer disease, or asthmatic patient. There was history 
of use of antipsychotics, risperidone, and quetepine fumarate. 
She had also used bromocriptine due to hyperprolactinemia.
She was married in a monogamous family setting to a 
37-year-old building contractor. Her husband was able to 
initiate and sustain erection and he ejaculated normally. 
He did not wear tight underwear. He was not a known 
hypertensive or diabetic. There was no previous scrotal 
trauma, groin surgery, or mumps orchitis. He consumed 
alcohol occasionally but did not smoke cigarette.
Examination revealed a middle-aged woman with the 
following anthropometric measurements: weight: 62 kg; 
height: 1.64 m; BMI: 23.1 kg/m2.
Examination of the head, neck, cardiovascular system (CVS), 
and respiratory system did not reveal any abnormalities. She 
had rudimentary breast development-Tanner stage III, with 
well-developed axillary hair, no palpable lumps or nodules 
in the breast, and no nipple discharge.
The abdomen was flat, moved with respiration, well-developed 
female pattern of pubic hair.
No areas of tenderness and no ascites were seen. Bowel sound 
is normoactive. Vaginal examination revealed small female 
external genitalia, short vagina, rudimentary cervix, and an 
anteverted uterus that sounds to 7 cm with some difficulties 
encountered at the level of the internal cervical os.
Based on the history and examination findings, an assessment 
of primary infertility secondary to gonadal dysgenesis 
was made. She was counseled on the diagnosis and its 
implications with regard to menstruation and fertility. She 
was placed on hormone replacement therapy and was advised 
to go for IVF using donor oocytes.
She did several investigations with results as follows:
FSH = 56.0 IU/L (3.9–12.0)
LH = 28.0 IU/L (1.5–8.0)
Prolactin = 16 mg/dL (5–35)
Estradiol = 23 pg/mL (30–100)
Day 21 progesterone: 1.6 ng/mL (2.0–25.0)
Testosterone: 0.4 ng/mL (0.2–1.0).
Cytogenetics Report: 46 XX
Pelvic ultrasound showed a small uterus measuring 56 mm by 
38 mm by 20 mm. Husband’s seminal fluid analysis revealed 
normal findings.
She was subsequently scheduled for in-vitro fertilization (IVF), 
egg donation, and embryo transfer. She had a failed IVF 
cycle using donor oocyte in 2015. In January 2017, she 
was booked for a repeat IVF and was commenced on IM 
estradiol valerate 10 mg weekly for 2 weeks, and thereafter, 
IM progesterone-in-oil 100 mg stat was given. She had 
withdrawal bleeding after 1 week and this was repeated 
for the next 2 months. Endoscratch was done, and the 
endometrium was then built up with weekly IM estradiol 
valerate.
She had IVF and Day 3 embryo transfer on February 14, 
2017. Two embryos were transferred into the endometrial 
cavity with the aid of a Labotech catheter under ultrasound 
guidance. First attempt at transfer was unsuccessful, but the 
second attempt was successful. She was then placed on luteal 
phase support with IM progesterone in oil 100 mg daily, IM 
estradiol valerate 10 mg weekly, and PO folic acid 5 mg daily.
Fourteenth-day post-transfer, pregnancy was biochemically 
confirmed with positive serum PT and hormonal support 
was continued until 12 weeks of gestation. Transvaginal 
ultrasound done at 5 weeks of gestational age also confirmed 
pregnancy showing a gestational sac with an identifiable fetal 
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pole. She had prophylactic cervical cerclage using McDonald 
Technique at gestational age of 13 weeks following and 
ultrasound scan that revealed a short cervical length of 
20 mm.
She booked for antenatal care at gestational age of 16W + 0D 
and she received two doses of tetanus toxoid and intermittent 
preventive therapy for malaria at 16W + 0D and 20W + 0D, 
respectively. Pregnancy remained uneventful until 37 weeks 
4 days of gestational age when she was admitted for elective 
cesarean section.
She was delivered of a live singleton male baby weighing 
3.5 kg with APGAR scores of 101 and 105. An intraoperative 
finding of poorly formed ovaries was made, although the 
fallopian tubes appeared grossly normal bilaterally. Cervical 
cerclage was removed immediately after the surgery. 
Postop condition was uneventful with a postop packed cell 
volume (PCV) of 32% and mother was discharged on third 
postoperative day. Baby was commenced on immunization 
according to the extended program for immunization. Six 
weeks postdelivery, both mother and baby were seen in a 
satisfactory condition.
Discussion
The case presented above is that of a Nigerian woman with 
complete gonadal dysgenesis (Karyotype 46, XX). In patients 
with 46, XX gonadal dysgenesis, there is a homozygote or 
heterozygote mutation of the FSH receptor gene.[3,6] This 
results in a female phenotype in the absence of secondary 
sex characteristics. It is a form of pure (complete) gonadal 
dysgenesis characterized by absence of well-differentiated 
gonads, but with normal internal and external genitalia. 
Patients have delayed puberty as well as primary amenorrhea 
as a result of ovarian insufficiency and they also have 
infertility. Hormone replacement therapy is needed for the 
initiation of female genital development.[7]
This patient typically had delayed development of secondary 
sexual characteristics and primary amenorrhea until the 
commencement of estrogen replacement therapy with oral 
contraceptive pills (OCPs) at the age of 19. This was as a 
result of the primary ovarian insufficiency.[3] As seen in this 
patient, there was also incomplete development of breasts 
due to low levels of circulating estradiol. There was however 
development of pubic and axillary hair probably due to the 
normal production of androgens by the adrenal gland.[8]
Gonadal dysgenesis is usually associated with an elevated 
level of FSH and LH and a low estrogen level.[9] From the 
laboratory findings, the level of the gonadotrophins was 
expectedly elevated, and estradiol level was also low. As they 
have defective gonads with complete germ cell deficiency and 
hypoplastic uterus, infertility is commonly seen. IVF with the 
use of donor oocytes is therefore often offered as an option 
to circumvent the challenge of infertility.[2,3]
Researchers[2,10] have postulated that the uterus in patients 
with gonadal dysgenesis though hypoplastic can be 
stimulated with exogenous hormones to carry pregnancy 
successfully and this was further confirmed by this study. 
However, the hypoplastic uterus may lack the receptors and 
the capacity to dilate and contract as expected during the 
process of labor.[2,10] It has also been suggested that there 
is reduced response of the uterus to induction of labor in 
such group of patients.[11] The choice of cesarean section 
as the mode of delivery was influenced by these reports as 
well as maternal choice following discussion of the options 
of delivery.
Prophylactic cervical cerclage was placed at 13 weeks 
as a result of an ultrasound finding of short cervical 
length of 20 mm. This was combined with progesterone 
supplementation. They have both been shown to reduce 
preterm birth and its associated complications in singleton 
pregnancies with short cervix.[12,13]
During the cesarean section, streak ovaries were observed. 
Though gonadectomy is often recommended in women with 
dysgenetic gonads, it was not necessary for this patient as 
the increased risk of ovarian malignancies in this group of 
patients has been particularly attributed to the presence of 
Y chromosome.[4,14] The presence of GBY region as well as 
the testes-specific protein gene on Y chromosome have been 
identified as prerequisites for malignant transformation.[7]
The need for early diagnosis in patients with gonadal 
dysgenesis cannot be overemphasized, as the long-term lack 
of estrogen is associated with several neurological, metabolic, 
psychological, and cardiovascular health problems. They are 
also at risk of early bone loss and osteoporosis.[9] Infertility, 
which is a consequence of the primary ovarian insufficiency 
in them, has been shown to be treatable through IVF with 
donor oocytes; therefore, patients should be identified early 
for prompt management.[8]
In conclusion, early presentation, in-depth evaluation, 
adequate counseling, and early institution of management 
can help women with gonadal dysgenesis resume their 
menstrual cycle and assume a good reproductive life. 
The effective use of hormone replacement therapy and 
application of assisted reproductive treatment techniques can 
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help them to circumvent the monstrous challenge of infertility 
associated with this condition, especially in an environment 
like ours where marital success is a factor of the woman’s 
ability to conceive and give birth.
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